Zymeworks Inc.
ZYME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $27,614 | $48,726 | $27,110 | $31,031 |
| % Growth | -43.3% | 79.7% | -12.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $27,614 | $48,726 | $27,110 | $31,031 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $35,578 | $34,449 | $35,738 | $37,063 |
| G&A Expenses | $14,100 | $14,900 | $17,000 | $16,200 |
| SG&A Expenses | $14,100 | $14,900 | $17,000 | $16,200 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $46 | $51 | -$15 | -$15 |
| Operating Expenses | $49,724 | $49,400 | $52,723 | $53,248 |
| Operating Income | -$22,110 | -$674 | -$25,613 | -$22,217 |
| % Margin | -80.1% | -1.4% | -94.5% | -71.6% |
| Other Income/Exp. Net | $3,844 | $2,805 | $3,473 | $4,426 |
| Pre-Tax Income | -$18,266 | $2,131 | -$22,140 | -$17,791 |
| Tax Expense | $1,336 | -$186 | $496 | $5,715 |
| Net Income | -$19,602 | $2,317 | -$22,636 | -$23,506 |
| % Margin | -71% | 4.8% | -83.5% | -75.8% |
| EPS | -0.26 | 0.031 | -0.3 | -0.31 |
| % Growth | -944.2% | 110.3% | 3.2% | – |
| EPS Diluted | -0.26 | 0.03 | -0.3 | -0.31 |
| Weighted Avg Shares Out | 75,768 | 75,337 | 75,171 | 75,847 |
| Weighted Avg Shares Out Dil | 75,775 | 77,378 | 75,226 | 75,879 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,529 | $3,426 | $3,424 | $4,082 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2,584 | $3,214 | $3,305 | $3,689 |
| EBITDA | -$15,682 | $2,591 | -$22,323 | -$18,543 |
| % Margin | -56.8% | 5.3% | -82.3% | -59.8% |